Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
NHS
Pharma
NICE reverses its call on Talzenna after Pfizer discount
With a price discount from Pfizer, England's NICE has given breast cancer treatment Talzenna a thumbs up after rejecting it six months ago.
Kevin Dunleavy
Jan 19, 2024 7:47am
Leo censured for 'extremely concerning' drug marketing breach
Mar 31, 2023 4:20am
Viatris considers backing out of UK's pricing scheme: report
Mar 3, 2023 11:46am
U.K. shuns immunocompromised, saying it won't buy AZ's Evusheld
Aug 15, 2022 11:35am
NICE green lights PrEP treatment for prevention of HIV
Dec 15, 2021 10:45am
Costly decision: NICE rejects Pfizer heart disease drug Vyndaqel
May 12, 2021 10:01am